| 000 | 01381 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515203736.0 | ||
| 264 | 0 | _c20100506 | |
| 008 | 201005s 0 0 eng d | ||
| 022 | _a1121-8428 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSimsek, Ismail | |
| 245 | 0 | 0 |
_aNo regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy. _h[electronic resource] |
| 260 |
_bJournal of nephrology _c |
||
| 300 |
_a119-23 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmyloidosis _xcomplications |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 |
_aFamilial Mediterranean Fever _xcomplications |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSerum Amyloid P-Component _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKaya, Ayper | |
| 700 | 1 | _aErdem, Hakan | |
| 700 | 1 | _aPay, Salih | |
| 700 | 1 | _aYenicesu, Mujdat | |
| 700 | 1 | _aDinc, Ayhan | |
| 773 | 0 |
_tJournal of nephrology _gvol. 23 _gno. 1 _gp. 119-23 |
|
| 999 |
_c19468103 _d19468103 |
||